Nanox to Report Second Quarter 2022 Financial Results on August 16, 2022
Nano-X Imaging Ltd (NASDAQ: NNOX) will announce its Q2 financial results ending June 30, 2022, on August 16, 2022, before market opening. CEO Erez Meltzer and CFO Ran Daniel will host a conference call at 8:30 a.m. ET for a business update. The company aims to enhance accessibility to medical imaging through its technology, which includes the Nanox System and Nanox.CLOUD. Forward-looking statements carry risks related to technology development and market acceptance, underscoring the uncertainties surrounding the company's future performance.
- Development of proprietary medical imaging technology aimed at improving accessibility and affordability.
- Focus on early detection of medical conditions, enhancing health outcomes.
- Risks related to the development and market acceptance of the Nanox System.
- Uncertainties regarding regulatory approvals and compliance.
Interested parties may register for the conference call using the following link: Nanox Q2 2022 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: Nanox Q2 2022 Earnings. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. The vision of Nanox is to increase the early detection of medical conditions that are discoverable by medical image technologies based on X-rays, which we believe is key to increasing early prevention and treatment, improving health outcomes, and, ultimately, saving lives. We are developing a holistic imaging solution, which includes the Nanox System, comprised of the Nanox.ARC using our novel MEMs X-ray source technology, and the Nanox.CLOUD, a companion cloud software, integrated with AI solutions and teleradiology services. For more information, please visit www.nanox.vision.
Forward-Looking Statements:
This press release may contain forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this press release are forward-looking statements. Such statements include, but are not limited to, any statements relating to the initiation, timing, progress and results of the Company’s research and development, manufacturing and commercialization activities with respect to its X-ray source technology and the Nanox.ARC, the ability to realize the expected benefits of its recent acquisitions and the projected business prospects of the Company and the acquired companies. In some cases, you can identify forward-looking statements by terminology such as “can,” “might,” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “should,” “could,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. Forward-looking statements are based on information the Company has when those statements are made or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause actual results to differ materially from those currently anticipated include risks related to (i) Nanox’s ability to complete development of the Nanox System; (ii) Nanox’s ability to successfully demonstrate the feasibility of its technology for commercial applications; (iii) Nanox’s expectations regarding the necessity of, timing of filing for, and receipt and maintenance of, regulatory clearances or approvals regarding its technology, the Nanox.ARC and Nanox.CLOUD from regulatory agencies worldwide and its ongoing compliance with applicable quality standards and regulatory requirements; (iv) Nanox’s ability to realize the anticipated benefits of the recent acquisitions, which may be affected by, among other things, competition, brand recognition, the ability of the acquired companies to grow and manage growth profitably and retain their key employees; (v) Nanox’s ability to enter into and maintain commercially reasonable arrangements with third-party manufacturers and suppliers to manufacture the Nanox.ARC; (vi) the market acceptance of the Nanox System and the proposed pay-per-scan business model; (vii) Nanox’s expectations regarding collaborations with third-parties and their potential benefits; (viii) Nanox’s ability to conduct business globally; (ix) changes in global, political, economic, business, competitive, market and regulatory forces; and (x) risks related to business interruptions resulting from the COVID-19 pandemic or similar public health crises, among other things.
For a discussion of other risks and uncertainties, and other important factors, any of which could cause Nanox’s actual results to differ from those contained in the Forward-Looking Statements, see the section titled “Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended
Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this report to conform these statements to actual results or to changes in the Company’s expectations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220801005575/en/
Nanox Imaging
ran.d@nanox.vision
Investors:
ICR Westwicke
mike.cavanaugh@westwicke.com
Source:
FAQ
When will Nano-X Imaging report its Q2 2022 financial results?
What time is the conference call for the Q2 2022 earnings report?
What is the primary focus of Nano-X Imaging's technology?
What challenges does Nano-X Imaging face regarding its product development?
